Dachaigh › Anemia Refractory le Barrachd Blastan
Sgrùdaidhean clionaigeach Anemia Refractory le Barrachd Blastan a’ fastadh anns na SA
Tha 19 sgrùdaidhean airson Anemia Refractory le Barrachd Blastan a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX6 sgrùdaidhean
- Seattle, WA5 sgrùdaidhean
- Washington, DC3 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- Boston, MA3 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
Le stàit
- Maryland3 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- New York3 sgrùdaidhean
- North Carolina3 sgrùdaidhean
- Ohio4 sgrùdaidhean
- Texas7 sgrùdaidhean
- Washington5 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
A’ fastadhÌre 1/2
Aoisean 12 gu 120 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06303193Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
A’ fastadhÌre 2
Aoisean 6 gu 70 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT01861106Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
A’ fastadhÌre 2
Aoisean 4 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT01174108Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT00801489Luspatercept + Darbepoetin in MDS
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07096297Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03383575Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07249346Personalized NK Cell Therapy in CBT
A’ fastadhÌre 2
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
A’ fastadhÌre 2
Suas gu aois 60 · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT03314974211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03670966MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
A’ fastadh
Aoisean 0 gu 25 · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT05794880A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT04256317Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
A’ fastadhÌre 1/2
1 Month – 25 Years · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06839456MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
A’ fastadhÌre 2
Suas gu aois 60 · Gach gnè · Air ùrachadh 6 Gibl 2026 · NCT05735717A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
A’ fastadhÌre 2
Aoisean 18 gu 66 · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06859424Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
A’ fastadhÌre 2
Suas gu aois 21 · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT04644016Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Dùbh 2025 · NCT06680752HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
A’ fastadhÌre 2
3 Months · Gach gnè · Air ùrachadh 12 Samh 2025 · NCT02143830Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.